Substance use and psychiatric comorbidities among medical inpatients: associations with length of stay, health-related quality of life, and functioning, with consideration for gender

Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Relate...

Descripción completa

Detalles Bibliográficos
Autores: Pons-Cabrera, Maria Teresa, Caballería Lamora, Elsa, Navarro Cortes, Lourdes, Borràs, Roger, Barrio Giménez, Pablo, Manthey, Jakob, Batalla Cases, Albert, Oliveras, Clara, Sagué Vilavella, Maria, Balcells Oliveró, Maria Mercè, Pintor Pérez, Luis, López Pelayo, Hugo
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/223051
Acceso en línea:https://hdl.handle.net/2445/223051
Access Level:acceso abierto
Palabra clave:Comorbiditat
Psiquiatria
Abús de substàncies
Comorbidity
Psychiatry
Substance abuse
Descripción
Sumario:Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Related Quality of Life (HRQoL), and functioning in 800 medical inpatients at a high-complexity academic hospital. Multivariate analyses demonstrated that psychiatric comorbidities were associated with reduced HRQoL (beta = -0.050, p-value = 0.017), and impaired functioning (beta = 3.4, p-value

Similares en LA Referencia